Stem cell therapy has emerged as a groundbreaking treatment option for corneal injuries, offering hope to individuals suffering from severe damage to the cornea.
Cornea is the transparent, dome-shaped front part of the eye that covers the iris and pupil. It plays a crucial role in focusing light and protecting the eye.
Recent clinical trials have shown promising results for a new treatment known as Cultivated Autologous Limbal Epithelial Cells, which uses a patient’s stem cells (body cells) to repair damaged corneas, with high success rates.
The CALEC treatment, developed at the Mass Eye and Ear research centre, is an innovative procedure that involves the removal of stem cells from a healthy eye with a biopsy, expanding them into a cellular tissue graft in a novel manufacturing process that takes two to three weeks, and then surgically transplanting the graft into the eye with a damaged cornea.
Mass Eye and Ear is a renowned…
Connect with us on our socials: